Skip to content

Clinical trials

Hemorrhagic Stroke trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhagic Stroke Country / region: Switzerland Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20131
20171
20182
20192
20222
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Basel, Switzerland4
Abbott Medical Devices2
CSL Behring1
Insel Gruppe AG, University Hospital Bern1
Integra LifeSciences Corporation1
Population Health Research Institute1
Prof. Dr. Jan Liman1
Reha Rheinfelden1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhagic Stroke12
Ischemic Stroke6
Stroke6
Coronary Artery Disease3
Anemia2
Atrial Fibrillation2
Hematologic Diseases2
Hemostatic Disorders2
Intracranial Hemorrhages2
Renal Insufficiency2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.